礼新医药 is a biopharmaceutical company based in China that focuses on the research and development of innovative drugs in the fields of tumor immunotherapy and tumor microenvironment. It develops large molecule antibodies and antibody-drug conjugates, and has various projects advancing into clinical research.

礼新医药

LaNova Medicines | 164 followers on LinkedIn. Care for life. Dedicate to innovation. | Founded in 2019 in Shanghai, China, LaNova Medicines is a clinical-stage biotechnology company committed to the discovery and development of novel biologic drugs for cancer treatment.

Led by industry veterans with a strong passion for innovation, we aim to operate as an R&amp;D engine and deliver transformative medicines to address the unmet clinical needs of cancer patients. Leveraging our proprietary technology platforms and deep understanding of the tumor microenvironment. we have built a differentiated pipeline of products and are striving to progress our programs toward the clinic.

LaNova Medicines Ltd. - Chief Operating Officer

Jason Li

LaNova Medicines - Sr.Director of Discovery

Wentao Huang

Director, Medical Sciences

Da Fei

LaNova Medicines - Medical Science VP

Sherry Qin

LaNova Medicines

LANO

COM:LANOVAMEDICINES

礼新医药